Intratumour injection of immunoglobulins labelled with the alpha-particle emitter 211At: analyses of tumour retention, microdistribution and growth delay.

gan Larsen, R. H., Bruland, O. S.
Cyhoeddwyd 1998

Selective localisation of two radiolabelled anti-sarcoma monoclonal antibodies in human osteosarcoma xenografts.

gan Bruland, O., Fodstad, O., Skretting, A., Pihl, A.
Cyhoeddwyd 1987

Demonstration of highly specific toxicity of the α-emitting radioimmunoconjugate(211)At-rituximab against non-Hodgkin's lymphoma cells

gan Aurlien, E, Larsen, R H, Kvalheim, G, Bruland, Ø S
Cyhoeddwyd 2000

Unexpected expression of the 250 kD melanoma-associated antigen in human sarcoma cells.

gan Godal, A., Bruland, O., Haug, E., Aas, M., Fodstad, O.
Cyhoeddwyd 1986

Analysis of the therapeutic gain in the treatment of human osteosarcoma microcolonies in vitro with 211At-labelled monoclonal antibody.

gan Larsen, R. H., Bruland, O. S., Hoff, P., Alstad, J., Rofstad, E. K.
Cyhoeddwyd 1994

Radioimmunotargeting of human tumour cells in immunocompetent animals.

gan Fjeld, J. G., Bruland, O. S., Benestad, H. B., Schjerven, L., Stigbrand, T., Nustad, K.
Cyhoeddwyd 1990

MicroRNA-15b is induced with E2F-controlled genes in HPV-related cancer

gan Myklebust, M P, Bruland, O, Fluge, Ø, Skarstein, A, Balteskard, L, Dahl, O
Cyhoeddwyd 2011

Gene expression reveals two distinct groups of anal carcinomas with clinical implications

gan Bruland, O, Fluge, Ø, Immervoll, H, Balteskard, L, Myklebust, M P, Skarstein, A, Dahl, O
Cyhoeddwyd 2008

Expression of DSG1 and DSC1 are prognostic markers in anal carcinoma patients

gan Myklebust, M P, Fluge, Ø, Immervoll, H, Skarstein, A, Balteskard, L, Bruland, O, Dahl, O
Cyhoeddwyd 2012

Two cases with fatal outcome following total lung irradiation for metastatic bone sarcoma

gan Lia, K., Bruland, Ø.S., Randem, H.L., Aksnes, L.H., Poulsen, J.P., Taksdal, I., Sundby Hall, K.
Cyhoeddwyd yn J Bone Oncol (2013)

An exploratory analysis of alkaline phosphatase, lactate dehydrogenase, and prostate-specific antigen dynamics in the phase 3 ALSYMPCA trial with radium-223

gan Sartor, O., Coleman, R. E., Nilsson, S., Heinrich, D., Helle, S. I., O’Sullivan, J. M., Vogelzang, N. J., Bruland, Ø., Kobina, S., Wilhelm, S., Xu, L., Shan, M., Kattan, M. W., Parker, C.
Cyhoeddwyd yn Ann Oncol (2017)